Daniel Barber - 09 Mar 2024 Form 4/A - Amendment Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role: President and CEO
Signature: /s/ Lori Braender, as Attorney-In-Fact
Issuer symbol: AQST
Transactions as of: 09 Mar 2024
Transactions value $: -$277,301
Form type: 4/A - Amendment
Filing time: 02 Oct 2024, 14:15:25 UTC
Date Of Original Report: 12 Mar 2024
Previous filing: 11 Mar 2024
Next filing: 11 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AQST	Common Stock	Tax liability	-$277K	-56.8K	-6.43%	$4.88	826K	09 Mar 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .

Content

Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 .